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Previous studies have indicated that ribonucleotide reductase may participate in a mechanism of cellular 
senescence, which involves modifications in deoxyribonucleotide pools, the products of the reductase reac- 
tion. Since very little information about the levels of these pools in senescing cells is currently available, 
an analysis of deoxyribonucleotide l vels was carried out in young, old and very old normal human diploid 
fibroblasts, as well as in a variant human tibroblast strain with an altered replicative life span. These studies 
indicated that there are marked age-related perturbations in these pools which imply that they may be fun- 
damentally important in a process determining the nonproliferative or senescent state. 
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1. INTRODUCTION 
An important step in the regulation of DNA syn- 
thesis in mammalian cells occurs at the conversion 
of ribonucleoside diphosphates to deox- 
yribonucleoside diphosphates; this reaction is car- 
ried out by ribonucleotide reductase, a complex 
and rate-limiting activity which appears to play an 
important role in the regulation of cell division and 
proliferation [ 1,2]. Alterations affecting this reac- 
tion influence a variety of cellular processes [11. 
We have observed that there are significant 
changes in ribonucleotide reductase levels during 
the senescence of cultured human diploid 
fibroblasts [3] which imply an important role for 
the enzyme in a mechanism of cellular senescence. 
In support of this point, hydroxyurea, whose site 
of action is ribonucleotide reductase, was used as 
a selective agent to isolate variant human 
fibroblast strains with altered enzyme activity and 
reduced replicative life spans [4]. It is possible that 
alterations in ribonucleotide reductase may in- 
fluence the aging process through modifications in 
deoxyribonucleotide pools, the eventual products 
of the reductase reaction. Very little information 
about deoxyribonucleotides in senescing cells is 
available. Therefore, to examine this important 
question in detail, deoxyribonucleotide pools in 
young, old, very old, and variant human 
fibroblasts were measured and compared. These 
studies indicate that there are significant age- 
related perturbations in these pools suggesting that 
their levels may be critically important in the 
establishment of the nonproliferative or senescent 
state. 
2. MATERIALS AND METHODS 
2.1. Cells and growth conditions 
The fetal lung fibroblast strains, HSC172, kind- 
ly provided by Dr Buchwald, University of Toron- 
to, was derived from a lZweek-old female fetus 
[5] and undergoes 95 + 5 population doublings in 
culture [4,6]. In agreement with other studies (e.g., 
[5]), we have observed that the karyotype of these 
cells is normal 46,Xx. The WCl-2 strain is a drug- 
resistant variant selected from HSC172 and ex- 
hibits a reduced lifespan of 76 + 2 doublings in 
culture [4]. Cells were routinely maintained on 
lOO-mm plastic tissue culture plates (Lux Scien- 
Published by Elsevier Science Publishers B. V. 
00145793/S/$3.30 0 1985 Federation of European Biochemical Societies 21 
Volume 179, number 1 FEBS LETTERS January 1985 
tific) in a-minimal essential medium (a-MEM; 
Flow Laboratories) supplemented with penicillin 
(100 units/ml), streptomycin sulfate (68 pg/ml) 
and 15% fetal bovine serum (Gibco) preselected 
for high plating efficiency characteristics. The cells 
were subcultured according to a rigid protocol us- 
ing 1:4 split ratio, counting two mean population 
doublings each time [4]. Purified trypsin (Sigma) 
at 0.1% in phosphate-buffered saline (PBS) was 
used to remove cells from the surface of plates. 
2.2. Cell volume measurements 
Cell volumes were determined by optical 
measurement of cell diameters directly [7] and with 
a Coulter electronic particle counter [8]. In agree- 
ment with other studies [8,9] very similar results 
(within 5%) were obtained with the two 
techniques. 
2.3. Determination of nucleotide pools 
The levels of intracellular deoxyribonucleotide 
pools in wild-type and drug-resistant cells were 
measured by high-performance liquid chromatog- 
raphy (HPLC) using a modification of the pro- 
cedures in [lo, 1 I]. We have described this pro- 
cedure [4,12,13]. Briefly, cells were plated at a den- 
sity of 2 x lo61150 mm tissue culture plate and 
grown for about 40 h. Cells were harvested and ex- 
tractions were made at 4°C. The cells were re- 
moved with trypsin (0.2%), counted, and cen- 
trifuged in as short a time as possible. The cell 
pellets were resuspended at 5 x 10’ cells/ml in PBS 
and a small aliquot of [3H]thymidine was added to 
estimate the dilution factor. This resuspension was 
then transferred to glass test tubes with sufficient 
70% perchloric acid to achieve a final concentra- 
tion of 0.5 M, and the tubes were placed on ice for 
30 min. Diethyl pyrocarbamate (100 pi/ml) and 
2.2% tri-hr-octylamine in Freon (2 vols to 1 vol. 
extract) were added to the extract and vortex- 
mixed for 2 min. The tubes were then centrifuged 
at low speed for 2 min and the supernatant was 
collected and immediately frozen at -65°C. 
The separation and identification of the deox- 
yribonucleotides first required the destruction of 
ribonucleotides with periodate and methylamine 
and the extracts were separated by HPLC on an 
anion-exchange resin. A Beckman model 332 gra- 
dient liquid chromatograph consisting of two 
model 1lOA pumps coordinated by a model 420 
22 
system controller programmer was used. The 
nucleotides were detected with a Beckman model 
160 detector at 254 nm, with maximum sensitivity 
of 0.001 AUFS (absorbance units full scale). A 
Partisil lo/25 SAX (Whatman) strong anion- 
exchange column (25 cm x 4.6 mm) preceded by a 
guard column (7.0 cm x 2.0 mm) was used in the 
separation process. Good resolution of the 4 deox- 
yribonucleotides was achieved using isocratic elu- 
tion with 0.25 M KHzP04 (Fisher, HPLC grade) 
and 0.25 M KC1 (Fisher, ACS grade), pH 5.0 at a 
flow rate of 2 ml/min. All buffers were filtered 
through a 0.45 pm membrane filter and degassed 
prior to use. Identification was by retention times 
as compared to known standards. The peaks were 
quantitated on the basis of peak weight. 
3. RESULTS AND DISCUSSION 
The deoxyribonucleotide pools were determined 
in young (passage no.29), old (passage no.86), and 
very old (passage no.923 fibroblast cultures, as well 
as in variant human diploid fibroblasts which con- 
tain altered ribonucleotide reductase activity. The 
results of these studies are summarized in tables 1 
and 2. The properties of the variant fibroblasts 
have been described [4]. In brief, 3 hydroxyurea- 
resistant clones were isolated and found to contain 
elevated CDP reductase activity, and a 20-40% 
reduction in replicative abilities, when compared 
to normal wild-type fibroblasts. The clone 
designated WCl-2 is one of these variant strains, 
and was examined after approx. 70 passages in 
culture, which is about 6 passage numbers from 
senescence for this strain [4]. Therefore, WCl-2 is 
situated between the old and very old cell cultures, 
Table 1 
Deoxyribonucleoside triphosphate pools (pm0115 X lo6 
cells) 
Cell strain TTP dCTP dATP dGTP 
HSC172-29 468 zk 71 107 +- 15 140 +- 21 40 + 12 
HSC172-86 388 f 92 89 k 7 235 + 32 31 + 11 
HSC172-92 248 + 10 45 f 10 180 f 20 23 + 15 
WCl-2 282 f 20 95 + 5 223 zk 8 13 * 5 
The values are the averages of 3 determinations 
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Table 2 
Deoxyribonucleoside triphosphate pools (taking cell 
volume into consideration) 
Cell strain TTP dCTP dATP dGTP 
WW duM) (uM) W) 
HSC 172-29’ 27.8 6.3 8.3 2.4 
HSC172-86b 7.9 1.8 4.8 0.8 
HSC172-92C 3.1 0.6 2.2 0.3 
WCl-2d 4.8 1.6 3.8 0.2 
a Cell volume: 3.38 with an SD of 1.6 
b Cell volume: 9.80 with an SD of 5.6 
’ Cell volume: 16.25 with an SD of 13.5 
d Cell volume: 11.68 with an SD of 7.1 
The values are the averages of 3 determinations 
which are about 10 and 3 passage numbers, respec- 
tively, from senescence [4,6]. 
Data on deoxyribonucleotide pools can be ex- 
pressed in two ways; either as pmol/cell number 
(as shown in table 1) or as ,uM (as shown in table 
2). The latter measurement takes into account the 
large differences in cell volume which occur during 
senescence [7]. 
It is evident that important changes occur in 
deoxyribonucleotides as cells age. When the data 
were analyzed (table 1) with respect o cell number 
(5 x lo6 cells), TTP declined by less than 20% bet- 
ween passages 29 and 86, and decreased by 
40-50% in very old passage 92 cells and the 
variant WCl-2 fibroblasts. The dCTP pool de- 
clined by 17% of low passage fibroblasts in 
passage 86 and by 58% in passage 92 cells. Deoxy 
GTP levels were reduced by 22% in passage 86 
cells, by 42% in passage 92 fibroblasts, and by 
67% in WCl-2 cells. No reductions in dATP pools 
were observed when examined as pmol/cell 
number; instead, this pool was 1.7-fold higher in 
passage 86 cells, 1.3-fold higher in passage 92 cells, 
and 1.6-fold higher in WCl-2 cells when compared 
to low passage human fibroblasts. 
When cell volume was taken into consideration, 
the pattern changed somewhat (table 2). In this 
case, TTP, dCTP and dGTP pools declined 
markedly to about 30% in old (passage 86) cells; 
about 10% in very old (passage 92) cells, and to 17, 
25, and 8%, respectively, in WCl-2 variant cells. 
The dATP concentration varied between about 
60% in old cells and 25% in very old fibroblasts. 
A general pattern emerged from these studies, in 
which old cells contained higher concentrations of 
all 4 deoxyribonucleotides than WCl-2 cells (in- 
termediate between old and very old), and except 
for dGTP, the WCl-2 cells contained higher levels 
of deoxyribonucleotides than very old fibroblasts. 
From these studies it is evident that in general, 
the deoxyribonucleotide pools are regulated in the 
same manner in aging and drug-resistant 
fibroblasts which contain altered ribonucleotide 
reductase; however, the aging process was ac- 
celerated in the variant cells [4]. Although very lit- 
tle is known about the biological effects generated 
by modifications in deoxyribonucleotide pools, it 
has been suggested that one or more of these com- 
pounds may be involved in a special way in trigger- 
ing the synthesis of DNA [14], and it is known that 
perturbations in deoxyribonucleotide pools have 
mutagenic effects [15,16], and may modify dif- 
ferentiation capabilities of mammalian cells [ 121. 
These changes in deoxyribonucleotide concentra- 
tions observed for the first time in this study 
(tables 1 and 2), may be fundamentally related to 
the finite proliferative abilities of cultured human 
diploid fibroblasts. When one or more of these 
specialized compounds of DNA synthesis decline 
below a critical threshold level required for DNA 
synthesis, the cells would lose their proliferative 
characteristics. For example, the control of cell cy- 
cle progression which is closely related to the pro- 
cess of senescence, has been described in terms of 
stochastic or random transition models [17-191. In 
these models, the initiation of DNA synthesis is 
governed by the probability that a small number of 
initiation factors will rise above a critical threshold 
concentration, and the synthesis of DNA will 
begin. If these factors are not elevated above this 
threshold, the probability of cell cycle progression 
remains very low. The results of this study are in 
keeping with the hypothesis that the deox- 
yribonucleotides belong to this select group of in- 
itiators of DNA synthesis, and participate in a fun- 
damental way, in a mechanism of cellular 
senescence. 
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